Publication |
Data |
|
Fish |
Anatomy
|
Arnold et al., 2022
|
Fig. 1
|
|
mafbauq4bh/uq4bh; nz101Tg; y7Tg
|
|
Lou et al., 2022
|
Fig. 2
|
|
mafbauq4bh/uq4bh; hkz015tTg/hkz015tTg
, 
mafbauq4bh/uq4bh; hkz015tTg/hkz015tTg; tsu11Tg/tsu11Tg
|
|
Chen et al., 2021
|
Figure 1
|
|
mafbahzu17/hzu17
|
|
|
Figure 2
|
|
mafbahzu17/hzu17
|
|
|
Figure 4
|
|
mafbahzu17/hzu17
|
|
|
Figure 5
|
|
mafbahzu17/hzu17
|
|
|
Figure 6
|
|
mafbahzu17/hzu17
|
- inner ear ionocyte atp1a1a.4 expression decreased amount, abnormal
- inner ear ionocyte atp1b1a expression decreased amount, abnormal
- inner ear ionocyte atp1b2b expression decreased amount, abnormal
- inner ear ionocyte atp6v1aa expression decreased amount, abnormal
- inner ear NaK ionocyte atp1a1a.4 expression decreased amount, abnormal
- inner ear NaK ionocyte atp1b1a expression decreased amount, abnormal
- inner ear NaK ionocyte atp1b2b expression decreased amount, abnormal
- inner ear vH ionocyte atp6v1aa expression decreased amount, abnormal
- inner ear vH ionocyte Ab6-atp6v1a labeling decreased amount, abnormal
- ionocyte apoptotic process increased rate, abnormal
- NaK ionocyte apoptotic process increased rate, abnormal
- NaK ionocyte decreased amount, abnormal
- vH ionocyte apoptotic process increased rate, abnormal
- vH ionocyte decreased amount, abnormal
|
|
Figure 7
|
|
mafbahzu17/hzu17
|
- cell cycle phase transition decreased process quality, abnormal
- head baxa expression increased amount, abnormal
- head bbc3 expression increased amount, abnormal
- head bcl2a expression decreased amount, abnormal
- head casp10 expression increased amount, abnormal
- head casp8 expression increased amount, abnormal
- head ccnd1 expression decreased amount, abnormal
- head ccne1 expression decreased amount, abnormal
- head cdk2 expression decreased amount, abnormal
- head cdk4 expression decreased amount, abnormal
- head cdk6 expression decreased amount, abnormal
- head cdkn1a expression increased amount, abnormal
- head cdkn1bb expression increased amount, abnormal
- head cdkn2a/b expression increased amount, abnormal
- head cdkn3 expression increased amount, abnormal
- head cul1a expression increased amount, abnormal
- head cul3a expression increased amount, abnormal
- head dhfr expression decreased amount, abnormal
- head e2f1 expression decreased amount, abnormal
- head e2f3 expression decreased amount, abnormal
- head foxa1 expression decreased amount, abnormal
- head mdm2 expression increased amount, abnormal
- head mdm4 expression decreased amount, abnormal
- head mycb expression decreased amount, abnormal
- head rangap1a expression decreased amount, abnormal
- head rb1 expression decreased amount, abnormal
- head tk1 expression decreased amount, abnormal
- head tp53 expression increased amount, abnormal
|
|
Figure 8
|
|
mafbahzu17/hzu17
|
|
Itoh et al., 2020
|
Fig. 8
|
|
mafbab337/b337; nkhspGFFDMC28CEt; nkuasgfp1aTg
, 
mafbankgsaizgffm35aGt/nkgsaizgffm35aGt; nkuasgfp1aTg; nns30Tg
|
|
Asakawa et al., 2018
|
Fig. 4
|
|
mafbankgsaizgffm35aGt/nkgsaizgffm35aGt; nkhgj4aEt
, 
mafbankgsaizgffm35aGt/+; nkhgj4aEt
, 
mafbankgsaizgffm35aGt/nkgsaizgffm35aGt; nkuasgfp1aTg
|
|
Ghosh et al., 2018
|
Fig. 3
|
|
mafbab337/b337
|
- rhombomere 5 celf2 expression absent, abnormal
- rhombomere 5 egr2b expression absent, abnormal
- rhombomere 5 gas6 expression absent, abnormal
- rhombomere 5 gbx1 expression absent, abnormal
- rhombomere 5 sema3fb expression absent, abnormal
- rhombomere 5 tox3 expression absent, abnormal
- rhombomere 5 absent, abnormal
- rhombomere 5 decreased size, abnormal
- rhombomere 6 gas6 expression absent, abnormal
- rhombomere 6 nr2f2 expression absent, abnormal
- rhombomere 6 absent, abnormal
|
Tran et al., 2017
|
Fig. 2
|
|
mafbab337/+
|
|
Dong et al., 2015
|
Fig. 5
|
|
WT + MO1-mafba
|
|
Koltowska et al., 2015
|
Fig. 1
|
|
mafbauq4bh/uq4bh; nz101Tg
, 
mafbauq4bh/uq4bh; nz101Tg; y7Tg
, 
mafbauq4bh/uq4bh
|
- dorsal longitudinal lymphatic vessel absent, abnormal
- intersegmental lymph vessel absent, abnormal
- lateral facial lymph vessel endothelial cell decreased amount, abnormal
- lymph vasculature aplastic, abnormal
- lymph vasculature hypoplastic, abnormal
- lymph vessel endothelial cell decreased amount, abnormal
- lymphangiogenesis decreased process quality, abnormal
- lymphatic branchial arch 1 endothelial cell decreased amount, abnormal
- medial facial lymph vessel endothelial cell decreased amount, abnormal
- otic vesicle morphology, abnormal
- otolithic lymph vessel endothelial cell decreased amount, abnormal
- thoracic duct absent, abnormal
|
|
Fig. 2
|
|
mafbauq4bh/uq4bh
|
|
|
Fig. 6
|
|
mafbauq4bh/uq4bh; nz101Tg
|
|
Ma et al., 2014
|
Fig. 1
|
|
mafbab337/b337
|
|
|
Fig. 2
|
|
mafbab337/b337
|
|
|
Fig. 3
|
|
mafbab337/b337
|
|
Zannino et al., 2012
|
Fig. 6
|
|
mafbab337/b337
|
|
Choe et al., 2008
|
Fig. 2
|
|
mafbab337/b337
|
|
Phenotype Annotation (1994-2006)
|
Fig. for (b337)
|
|
mafbab337/b337 (AB)
|
|
Eckfeldt et al., 2005
|
Fig. Table 1
|
|
WT + MO1-mafba
|
|
|
Fig. Table S7
|
|
sd2Tg; y1Tg + MO1-mafba
|
|
Riley et al., 2004
|
Fig. 5
|
|
mafbab337/b337 (AB)
|
|
Moens et al., 1998
|
Fig. 5
|
|
mafbab337/b337 (AB)
|
|
|
Fig. 6
|
|
mafbab337/b337 (AB)
|
|
Prince et al., 1998
|
Fig. 6
|
|
mafbab337/b337 (AB)
|
|
Moens et al., 1996
|
Fig. 2
|
|
mafbab337/b337 (AB)
|
|
|
Fig. 3
|
|
mafbab337/b337 (AB)
|
|